Clinical Trial Detail

NCT ID NCT03492125
Title A Study Of The Selective PKC-beta Inhibitor MS- 553
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors MingSight Pharmaceuticals, Inc.
Indications

CLL/SLL

Therapies

MS-553

Age Groups: senior adult

No variant requirements are available.